Wavefront aberrometers Market Is Growing With the Growing Burden of Eye Diseases

 Wavefront aberrometers are diagnostic devices used to measure the total refractive aberrations of the eye. They measure aberrations of the eye from the cornea to the retina. It is widely used to diagnose and cure eye ailments. It helps to screen patients with compromised vision and allows physicians to measure highly distorted eyes. Wavefront aberrometers are also used in laser eye surgery to ensure high accuracy. With the help of this device, every variation that occurs in the eye can be measured. An aberrometer helps doctors to screen patients whose vision may be compromised by these conditions.

Wavefront aberrometers are diagnostic devices used to measure the total refractive aberrations of the eye. They measure aberrations of the eye from the cornea to the retina. It is widely used to diagnose and cure eye ailments. It helps to screen patients with compromised vision and allows physicians to measure highly distorted eyes. Wavefront aberrometers are also used in laser eye surgery to ensure high accuracy. With the help of this device, every variation that occurs in the eye can be measured. An aberrometer helps doctors to screen patients whose vision may be compromised by these conditions. The growth of the wavefront aberrometer market is mainly driven by the growing burden of eye diseases worldwide. According to the Centers for Disease Control and Prevention, around 12 million people in the United States, aged 40 years and over, have vision impairment, including 1 million who are blind, 3 million who have vision impairment after correction, and 8 million who have vision impairment due to uncorrected refractive error. Uncorrected refractive errors are one of the major reasons for blindness. Thus, with increasing prevalence, the demand for novel diagnostic tools is also increasing, driving the wavefront aberrometers market growth. For instance, in August 2018, Essilor Instruments launched the new Wave Analyzer Medica (WAM700+) Wavefront Aberrometer for the simplified screening of patient eye wellness. The instrument features complete anterior chamber analysis and visual need assessment to assess conditions such as glaucoma, cataract, and keratoconus. According to the American Academy of Ophthalmology (AAO), cataracts affect more than 24.4 million Americans age 40 and older, and by age 75, approximately half of all Americans have cataracts. Thus, with the increasing incidence of cataracts and glaucoma, the demand for diagnostic tools is also increasing. In September 2018, Johnson & Johnson Vision launched the Food and Drug Administration (FDA) approved design Refractive Studio. The newly launched studio uses topography-integrated, wavefront-guided technology, which allows doctors to take a precise measurement of the eye inside and out to deliver a LASIK procedure personalized to the individual patient. It is approved for hyperopia, myopia, and mixed astigmatism. Technological advancements in the aberrometers and increasing research and development activities to improve the visual outcomes are some of the major factors driving the wavefront aberrometers market growth. The wavefront aberrometers market is witnessing robust growth, in North America, due to the advancements in the diagnosis and treatment of many ocular diseases, such as refractive errors, as well as the increasing number of ophthalmic cases in the region.


For instance, in August 2018, Essilor Instruments launched the new Wave Analyzer Medica (WAM700+) Wavefront Aberrometer for the simplified screening of patient eye wellness. The instrument features complete anterior chamber analysis and visual need assessment to assess conditions such as glaucoma, cataract, and keratoconus. According to the American Academy of Ophthalmology (AAO), cataracts affect more than 24.4 million Americans age 40 and older, and by age 75, approximately half of all Americans have cataracts. Thus, with the increasing incidence of cataracts and glaucoma, the demand for diagnostic tools is also increasing.

In September 2018, Johnson & Johnson Vision launched the Food and Drug Administration (FDA) approved design Refractive Studio. The newly launched studio uses topography-integrated, wavefront-guided technology, which allows doctors to take a precise measurement of the eye inside and out to deliver a LASIK procedure personalized to the individual patient. It is approved for hyperopia, myopia, and mixed astigmatism. Technological advancements in the aberrometers and increasing research and development activities to improve the visual outcomes are some of the major factors driving the wavefront aberrometers market growth... Read more


Post a Comment

Previous Post Next Post